What is wrong in doing good?
British Journal of Haematology · 2023
DOI: 10.1111/bjh.19019 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, 2023. Verfasst von Heinz Zoller und 2 weiteren Autor:innen. Beteiligte Einrichtung: Christian Doppler Laboratory on Iron and Phosphate Biology, Department of Medicine I, Medical University of Innsbruck, Innsbruck, Austria. Hauptthemen laut MEDLINE: Anemia, Iron-Deficiency, Hypophosphatemia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Hypophosphataemia is a common side‐effect in patients with iron deficiency anaemia treated with ferric carboxymaltose, which is not a class effect of all intravenous (IV) iron formulations. The report by Chu et al. shows that moderate and severe hypophosphataemia is common and can even require IV supplementation of phosphate with unknown long‐term consequences. Commentary on: Chu et al. Incidence and predictors of hypophosphataemia after ferric carboxymaltose use—a 3‐year experience from a single institution in Singapore. Br J Haematol 2023;202:1199–1204.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Christian Doppler Laboratory on Iron and Phosphate Biology, Department of Medicine I, Medical University of Innsbruck, Innsbruck, Austria.
ORCID-Profile: Heinz Zoller
Zitieren
APA
Zoller, H., Wagner, S., & Schaefer, B. (2023). What is wrong in doing good?. British Journal of Haematology. https://doi.org/10.1111/bjh.19019
Vancouver
Zoller H, Wagner S, Schaefer B. What is wrong in doing good?. British Journal of Haematology. 2023. doi:10.1111/bjh.19019
BibTeX
@article{Zoller2023,
author = {Zoller, Heinz and Wagner, Sonja and Schaefer, Benedikt},
title = {What is wrong in doing good?},
journal = {British Journal of Haematology},
year = {2023},
doi = {10.1111/bjh.19019}
}
EUVIMED